Therapeutic Advances in Infectious Disease
Scope & Guideline
Driving excellence in the fight against infectious diseases.
Introduction
Aims and Scopes
- Infectious Disease Epidemiology and Public Health:
Research focusing on the trends, prevalence, and risk factors associated with infectious diseases in various populations, emphasizing the need for effective public health interventions. - Clinical Management and Treatment Advances:
Investigations into novel therapeutic approaches, treatment protocols, and clinical outcomes for various infectious diseases, including drug-resistant infections and emerging pathogens. - Microbial Pathogenesis and Resistance Mechanisms:
Studies exploring the mechanisms of microbial virulence, resistance to antimicrobials, and the implications for treatment strategies. - Fungal and Parasitic Infections:
Dedicated research on the diagnosis, treatment, and epidemiological aspects of fungal and parasitic infections, with a focus on their growing significance in clinical practice. - HIV/AIDS and Related Co-infections:
Research targeting the complexities of HIV/AIDS management, co-infections, and the socio-behavioral factors influencing treatment and prevention. - Innovative Diagnostic Techniques:
Exploration of new diagnostic methodologies, including molecular techniques and point-of-care testing, to improve the identification and management of infectious diseases. - Global Health Challenges and Strategies:
Addressing infectious diseases within the context of global health, including the impact of socio-economic factors and health inequities on disease spread and management.
Trending and Emerging
- COVID-19 Research and Long-term Effects:
A significant increase in studies addressing the implications of COVID-19, including long-term health effects, treatment strategies, and public health responses. - Antimicrobial Stewardship and Resistance Management:
Growing attention on strategies to combat antimicrobial resistance, including stewardship programs and innovative treatment approaches for resistant infections. - Mental Health Impacts of Infectious Diseases:
Emerging research on the psychological effects of infectious diseases, particularly in the context of pandemics and chronic infections, highlighting the importance of holistic care. - Telemedicine and Digital Health Solutions:
Increased exploration of telehealth and digital health interventions for managing infectious diseases, particularly in resource-limited settings, as a response to the COVID-19 pandemic. - Community-based Health Interventions:
Focus on community engagement and participatory approaches to improve health outcomes related to infectious diseases, emphasizing local knowledge and practices. - Global Health Equity and Access to Care:
Heightened awareness of health disparities and the need for equitable access to infectious disease prevention and treatment services, particularly in low-resource settings.
Declining or Waning
- Traditional Antibiotic Treatment Protocols:
Research on conventional antibiotic regimens is becoming less prominent as the focus shifts toward innovative therapies, combination treatments, and addressing antibiotic resistance. - Non-communicable Disease Co-infections:
There seems to be a reduction in studies specifically addressing the intersection of non-communicable diseases with infectious diseases, as the journal leans more towards acute infectious disease management. - Historical Perspectives on Infectious Diseases:
Less emphasis on historical analyses and retrospective studies of infectious disease outbreaks, possibly due to the urgent need for current and actionable research. - Vaccine Development for Established Diseases:
There is a noticeable decline in research dedicated solely to vaccines for already established infectious diseases, as the focus is shifting towards novel vaccines for emerging pathogens. - In-depth Case Studies from Limited Geographies:
Fewer publications are focusing on localized case studies, indicating a trend towards broader epidemiological studies that encompass wider geographic and demographic perspectives.
Similar Journals
GERMS
Empowering practitioners with vital insights in epidemiology.GERMS is a multidisciplinary journal published by the EUROPEAN ACAD HIV-AIDS & INFECTIOUS DISEASES, dedicated to advancing knowledge in the fields of epidemiology, immunology, infectious diseases, and microbiology. Since its inception in 2011, the journal has provided a crucial platform for researchers and practitioners to share innovative studies, clinical findings, and public health insights, with an eye on improving health outcomes globally. With an ISSN of 2248-2997 and a consistent publication trajectory leading up to 2024, GERMS is recognized in the third quartile across several categories, reflecting its growing impact and relevance in the scientific community. Authors and readers benefit from a range of access options, fostering the dissemination of vital research findings. As a journal situated in Romania, it also addresses regional health challenges while contributing to the broader discourse on infectious diseases and public health. GERMS is not just a repository of knowledge, but a vital resource for those engaged in combating infectious diseases and promoting health equity.
Infectious Disease Reports
Exploring innovative solutions for a healthier tomorrow.Infectious Disease Reports is a premier open-access journal published by MDPI, dedicated to advancing the field of infectious diseases. Since its inception in 2009, this journal has established itself as a significant platform for disseminating cutting-edge research, reviews, and case studies, critical for global health. With a commendable Q2 ranking in the category of Infectious Diseases and a Scopus rank of #140 out of 344, it is recognized for its impactful contributions to medical research, holding a 59th percentile in its field. The journal aims to provide comprehensive insights into various dimensions of infectious diseases, ranging from epidemiology to novel treatment modalities. As an open-access publication, Infectious Disease Reports ensures that its articles are freely available to a wide audience, fostering collaborative efforts among researchers, healthcare professionals, and students worldwide. With its ongoing commitment to excellence, the journal plays an essential role in shaping the future of infectious disease research.
Current Fungal Infection Reports
Advancing the understanding of fungal infections.Current Fungal Infection Reports is an essential academic journal dedicated to the rapidly evolving field of mycology, specifically focusing on the diagnosis, treatment, and epidemiology of fungal infections. Published by Springer, this journal aims to provide a comprehensive platform for researchers, healthcare professionals, and scholars to disseminate groundbreaking findings and insights into the complexities surrounding fungal diseases. With an ISSN of 1936-3761 and an E-ISSN of 1936-377X, the journal is recognized in the Q3 category for Infectious Diseases as of 2023 and holds a Scopus rank of #199 out of 344 in its field, showcasing its growing influence. Although not currently open access, Current Fungal Infection Reports remains an important resource for those wishing to stay updated on key developments and trends within this critical area of global health. Through its commitment to advancing knowledge and fostering academic exchange, the journal plays a crucial role in combating the challenges posed by fungal infections, making it a must-read for anyone involved in infectious disease research and treatment.
Reviews and Research in Medical Microbiology
Illuminating the Evolving Landscape of Microbial ResistanceReviews and Research in Medical Microbiology is a premier academic journal published by LIPPINCOTT WILLIAMS & WILKINS, focusing on groundbreaking research and comprehensive reviews that advance the understanding of medical microbiology. With an ISSN of 2770-3150 and an E-ISSN of 2770-3169, this journal serves as an essential resource for researchers, healthcare professionals, and students dedicated to the study of pathogens, infectious diseases, and microbial mechanisms affecting health. While the journal currently does not offer open access, its rigorous peer-review process ensures that only high-quality, impactful research is disseminated to the scientific community. The journal aims to bridge gaps in knowledge by presenting cutting-edge studies that explore novel therapeutic strategies, diagnostic methods, and the evolving landscape of microbial resistance. Nestled in the heart of Philadelphia, this journal proudly contributes to the advancement of medical microbiology and is an indispensable platform for the publication of critical findings that shape clinical practices and research trajectories in the field.
MICROBIAL PATHOGENESIS
Illuminating the Pathways of Infection and HealthMICROBIAL PATHOGENESIS, published by Academic Press Ltd - Elsevier Science Ltd, is a prominent journal in the fields of Infectious Diseases and Microbiology, with a notable impact factor and classified in the Q2 quartile for both categories as of 2023. Since its inception in 1986, this journal has provided a platform for the dissemination of cutting-edge research that enhances our understanding of microbial infections and their implications in health and disease. The journal is indexed in Scopus, ranking #80 among 344 in Infectious Diseases and #57 among 182 in Microbiology, underscoring its significant contribution to the scientific community. Although it operates under a traditional subscription model, the content is vital for researchers, professionals, and students focused on the dynamics of microbial pathogenesis and the development of innovative therapeutic strategies. The journal's comprehensive scope aims to foster advancements in this critical area of study, bridging the gap between laboratory research and clinical applications.
Annals of Clinical Microbiology and Antimicrobials
Elevating scientific dialogue in microbiology and medicine.Annals of Clinical Microbiology and Antimicrobials, published by BMC, is a leading open-access journal that has been fostering scientific discourse in the fields of microbiology and infectious diseases since its inception in 2002. With an established reputation for excellence, this journal is positioned in the prestigious Q1 category across multiple disciplines, including Infectious Diseases, Medicine (miscellaneous), and Medical Microbiology as of 2023. This journal serves as a vital platform for researchers, healthcare professionals, and students, promoting the latest advancements in clinical microbiology and antimicrobial research. Access to its invaluable content is open to all, reflecting the commitment to disseminate knowledge universally. The Annals of Clinical Microbiology and Antimicrobials is based in the United Kingdom and continues to pave the way for innovation and discussions that shape the future of clinical practices in microbiology.
Mediterranean Journal of Infection Microbes and Antimicrobials
Exploring the intricate world of microbes and health.Mediterranean Journal of Infection Microbes and Antimicrobials is a distinguished open-access journal published by GALENOS PUBL HOUSE, dedicated to advancing the understanding of infectious diseases and microbiology. Since its inception in 2011, this journal has been a vital resource for researchers, professionals, and students interested in the intricate world of microbes and their impacts on human health. With its ISSN 2147-673X, the journal has progressively gained visibility, although it currently holds a Q4 ranking in multiple categories including Immunology and Microbiology, and Infectious Diseases for the year 2023. The journal operates from its headquarters in Istanbul, Turkey, and features a rich array of articles that contribute to the field’s body of knowledge. As a platform enhancing the accessibility of research, it invites submissions from global contributors to foster collaboration and innovation in tackling microbial challenges.
Southern African Journal of Infectious Diseases
Connecting knowledge to combat infectious diseases.Southern African Journal of Infectious Diseases is a pivotal platform for the dissemination and advancement of research in the field of infectious diseases, with a particular focus on issues significant to the Southern African region. Published by AOSIS, this Open Access journal has been committed to providing accessible scholarly content since 2016, enabling researchers and practitioners to stay updated with the latest developments in infectious disease epidemiology, prevention, and management. With the ISSN 2312-0053 and E-ISSN 2313-1810, the journal invites submissions that explore diverse topics, including but not limited to clinical studies, public health policies, and innovative treatment methodologies. The Southern African Journal of Infectious Diseases is an essential resource for academics, professionals, and students dedicated to combating infectious diseases and improving health outcomes in the region, fostering a collaborative approach to research and knowledge sharing.
MIKROBIYOLOJI BULTENI
Advancing the Frontiers of MicrobiologyMIKROBIYOLOJI BULTENI, with ISSN 0374-9096, is a prestigious academic journal published by the ANKARA MICROBIOLOGY SOC, located in Ankara, Turkey. Established in 1973, this journal has been a vital conduit for disseminating research in the fields of Immunology, Microbiology, and Infectious Diseases, garnering a reputation as a significant contributor to the scientific community. The journal is currently ranked in the Q3 category within Immunology and Microbiology (miscellaneous), and Infectious Diseases, indicating its impactful presence amidst contemporary research. With access options that may be restricted, MIKROBIYOLOJI BULTENI actively welcomes submissions that advance the understanding of critical microbiological principles and practices, thereby supporting both national and international research efforts. Researchers, professionals, and students are encouraged to explore the latest findings shared in this journal, as it continually shapes the landscape of microbiology and infectious disease studies through its comprehensive and rigorous peer-reviewed publications.
CLINICAL MICROBIOLOGY AND INFECTION
Advancing the Science of InfectionCLINICAL MICROBIOLOGY AND INFECTION is a leading journal published by Elsevier Science Ltd, dedicated to advancing the field of infectious diseases and clinical microbiology. With its ISSN 1198-743X and E-ISSN 1469-0691, this esteemed journal has maintained its influential presence since 1995, showcasing high-impact research that addresses critical issues in the diagnosis, treatment, and prevention of infections. Ranked in the Q1 quartile for Infectious Diseases, Medicine (miscellaneous), and Microbiology (medical) categories, and boasting impressive Scopus rankings of #12 and #7 respectively, it sits at the forefront of scientific inquiry in these disciplines. Although it is not an Open Access journal, it provides comprehensive access options for institutions and individuals, ensuring the dissemination of vital research findings. As the field of clinical microbiology continues to evolve, CLINICAL MICROBIOLOGY AND INFECTION remains an essential resource for researchers, clinicians, and students aiming to stay informed on the latest developments and breakthroughs in understanding infectious diseases.